Monday, February 20, 2012

FDA To Review Inhalable Caffeine

FDA To Review Inhalable Caffeine
U.S. Food and Drug Administration officials plan to investigate whether inhalable caffeine sold in lipstick-sized canisters is safe for consumers and if its manufacturer was right to brand it as a dietary supplement. AeroShot went on the market late last month in Massachusetts and New York; it’s also available in France. Consumers put one end of the canister in their mouths and breathe in, releasing a fine powder that dissolves almost instantly. Each plastic canister contains vitamin B, plus 100 milligrams of caffeine powder, about the equivalent of the caffeine in a large cup of coffee. AeroShot inventor, Harvard biomedical engineering professor David Edwards, says the product is safe and doesn’t contain taurine and other common additives used to enhance the caffeine effect in energy drinks. AeroShot didn’t require FDA review before hitting the U.S. market because it’s sold as a dietary supplement. But New York’s U.S. Sen. Charles Schumer said he met with FDA Commissioner Dr. Margaret Hamburg and she agreed to review the safety and legality of AeroShot. Schumer said he fears the product will be used as a club drug so that young people can drink until they drop.